Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
The article highlights FDNA’s innovative AI algorithm that detects genetic conditions using just a photo of a patient’s face. The technology, embedded in FDNA‘s Face2Gene platform, analyzes facial features to identify phenotypic markers associated with various genetic disorders. Utilizing an extensive database and machine learning, the AI can quickly and precisely diagnose conditions that traditional methods might overlook. This advancement promises earlier interventions and improved treatment strategies for patients with genetic conditions. The article shows the transformative potential of FDNA’s approach, paving the way for more precise and non-invasive decision-support tools in healthcare.
